- Filed
- Jan 16, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q2 2024 · Jun 30, 2024 | $10.59M |
| Long Term Debt | Q2 2024 · Dec 31, 2023 | $11.84M |
| Short Term Debt | Q2 2024 · Jun 30, 2024 | $7.86M |
| Short Term Debt | Q2 2024 · Dec 31, 2023 | $10.47M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $16.37M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $24.02M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $245.28M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $253.26M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $270.81M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $280.24M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $104.07M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $121.24M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $287.12M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $309.45M |
| Eps Diluted | Q2 2024 · Jun 30, 2024 | −$0.45 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.32 |
| Eps Basic | Q2 2024 · Jun 30, 2024 | −$0.45 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.32 |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 26.88M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $4.12M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $10.49M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $34.36M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $44.96M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $15.02M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$8.62M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$1.38M |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $13.65M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $131.97M |
| Revenue | Q2 2024 · Jun 30, 2023 | $145.62M |